Westside Investment Management Inc. Takes $139,000 Position in Henry Schein, Inc. (NASDAQ:HSIC)

Westside Investment Management Inc. bought a new stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 2,000 shares of the company’s stock, valued at approximately $139,000.

Several other large investors also recently added to or reduced their stakes in HSIC. Boston Partners bought a new stake in shares of Henry Schein during the 1st quarter valued at $99,903,000. JPMorgan Chase & Co. lifted its position in shares of Henry Schein by 22.1% during the 1st quarter. JPMorgan Chase & Co. now owns 2,426,917 shares of the company’s stock valued at $145,882,000 after acquiring an additional 439,922 shares during the period. First Trust Advisors LP lifted its position in shares of Henry Schein by 87.1% during the 1st quarter. First Trust Advisors LP now owns 868,694 shares of the company’s stock valued at $52,217,000 after acquiring an additional 404,487 shares during the period. Janus Henderson Group PLC lifted its position in shares of Henry Schein by 31.5% during the 1st quarter. Janus Henderson Group PLC now owns 1,581,637 shares of the company’s stock valued at $95,072,000 after acquiring an additional 378,634 shares during the period. Finally, State of Wisconsin Investment Board lifted its position in shares of Henry Schein by 226.5% during the 1st quarter. State of Wisconsin Investment Board now owns 426,035 shares of the company’s stock worth $25,609,000 after buying an additional 295,557 shares during the last quarter.

Henry Schein stock traded down $3.06 during trading hours on Tuesday, hitting $61.48. The stock had a trading volume of 997,581 shares, compared to its average volume of 1,244,742. The company has a current ratio of 1.65, a quick ratio of 0.93 and a debt-to-equity ratio of 0.34. The company has a market capitalization of $9.82 billion, a PE ratio of 14.89, a price-to-earnings-growth ratio of 2.36 and a beta of 0.84. Henry Schein, Inc. has a one year low of $56.58 and a one year high of $72.81. The business has a 50 day moving average of $68.86.

Henry Schein (NASDAQ:HSIC) last posted its earnings results on Tuesday, August 6th. The company reported $0.84 EPS for the quarter, beating the consensus estimate of $0.83 by $0.01. The firm had revenue of $2.45 billion during the quarter, compared to the consensus estimate of $2.48 billion. Henry Schein had a return on equity of 18.35% and a net margin of 4.10%. The business’s quarterly revenue was up 5.7% on a year-over-year basis. During the same period last year, the company earned $1.04 earnings per share. As a group, analysts anticipate that Henry Schein, Inc. will post 3.46 EPS for the current fiscal year.

Several analysts recently weighed in on HSIC shares. Guggenheim started coverage on Henry Schein in a research report on Wednesday, April 17th. They set a “buy” rating and a $72.00 price objective for the company. Craig Hallum restated a “buy” rating and set a $77.00 price objective (up from $72.00) on shares of Henry Schein in a research report on Wednesday, May 8th. Barrington Research upped their price objective on Henry Schein from $72.00 to $75.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 8th. Wolfe Research started coverage on Henry Schein in a research report on Thursday, May 30th. They set an “underperform” rating for the company. Finally, Zacks Investment Research downgraded Henry Schein from a “buy” rating to a “hold” rating and set a $76.00 price objective for the company. in a research report on Wednesday, June 19th. Seven analysts have rated the stock with a sell rating, nine have given a hold rating and four have given a buy rating to the company. The company presently has an average rating of “Hold” and a consensus target price of $74.13.

In other Henry Schein news, CFO Steven Paladino sold 20,712 shares of the stock in a transaction dated Wednesday, June 19th. The stock was sold at an average price of $72.17, for a total value of $1,494,785.04. Following the completion of the transaction, the chief financial officer now directly owns 166,233 shares in the company, valued at $11,997,035.61. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Paul Brons sold 1,758 shares of the stock in a transaction dated Wednesday, June 12th. The shares were sold at an average price of $70.96, for a total value of $124,747.68. Following the completion of the transaction, the director now owns 17,582 shares of the company’s stock, valued at $1,247,618.72. The disclosure for this sale can be found here. Insiders sold 49,668 shares of company stock valued at $3,572,423 over the last quarter. Corporate insiders own 1.06% of the company’s stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

See Also: Stop Order

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.